Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark generics (europe) ltd - ropinirole hydrochloride - film coated tablet - 0.25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark generics (europe) ltd - ropinirole hydrochloride - film coated tablet - 0.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark generics (europe) ltd - ropinirole hydrochloride - film coated tablet - 1 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark generics (europe) ltd - ropinirole hydrochloride - film coated tablet - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark generics (europe) ltd - ropinirole - film coated tablet - 5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - perindopril tert-butylamine indapamide - tablets - 2/0.625 mg/mg

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - perindopril tert-butylamine indapamide - tablets - 4/1.25 mg/mg

European Union - English - EMA (European Medicines Agency)

glenmark pharmaceuticals s.r.o.  - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode. in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

European Union - English - EMA (European Medicines Agency)

glenmark pharmaceuticals s.r.o.  - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode.in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - olmesartan medoxomil - film coated tablet - 10 milligram - angiotensin ii antagonists, plain - angiotensin ii antagonists - treatment of essential hypertension in adults and treatment of hypertension in children and adolescents from 6 to less than 18 years of age